Agenus Inc. (Nasdaq: AGEN), a leader in immuno-oncology, today announced participation in a panel discussion at the B. Riley Securities Precision Oncology & Radiopharma Investor Conference that will ...

Agenus Inc. ("Agenus") (Nasdaq: AGEN), a leader in developing novel immunological agents to treat various cancers, today announced the Company will release its fourth quarter and year end 2024 ...

Dr. Marc Siegel from NYU Langone Health confirmed that a small percentage of vaccinated people suffering from prolonged side ...

The study revealed that people with PVS symptoms had lower levels of two types of white blood cells while people with PVS who ...

Your immune system harbors a lifetime's worth of information about threats it's encountered - a biological Rolodex of baddies ...

For a majority of people, the COVID vaccine doesn’t cause adverse health effects — but a small percentage experience chronic ...

Devendra Barlewar, a 45-year-old scientist at Defence Research and Development Organisation (DRDO), underwent a four-hour ...

Receptors on B and T cells hint at what the immune system is targeting. An AI approach called Mal-ID developed increases diagnostic accuracy, particularly for autoimmune diseases.

A machine learning algorithm that analyzes immune "fingerprints" could be used to detect complex, hard-to-diagnose diseases.

South Korean firm Celltrion announced that the European Commission (EC) has granted marketing authorization for Avtozma ...

Biocon share price rose by 2.5% after its arm launched Yesintek, a biosimilar for autoimmune disorders in the US. Approved ...

Researchers analyzed blood samples from 42 participants who reported PVS symptoms and 22 individuals who did not.